We are live on ! Find out more
TCM

Tributary Capital Management Portfolio holdings

AUM $1.22B
1-Year Est. Return 44.12%
This Fund
S&P 500
This Quarter Est. Return
+12.18%
1 Year Est. Return
+44.12%
3 Year Est. Return
+82.34%
5 Year Est. Return
+109.28%
10 Year Est. Return
+466.43%
AUM
$1.32B
AUM Growth
+$30.1M
Cap. Flow
-$106M
Cap. Flow %
-8.04%
Top 10 Hldgs %
20.06%
Holding
237
New
7
Increased
42
Reduced
173
Closed
14

Top Sells

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$16.9M
2
OMCL icon
Omnicell
OMCL
+$13.3M
3
BOOT icon
Boot Barn
BOOT
+$11M
4
ONTO icon
Onto Innovation
ONTO
+$8.96M
5
AMBA icon
Ambarella
AMBA
+$7.41M

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Industrials 16.46%
3 Financials 14.57%
4 Healthcare 12.82%
5 Consumer Discretionary 12.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YETI icon
126
Yeti Holdings
YETI
$3.95B
$1.59M 0.12%
19,200
-2,000
-9% -$184K
RNG icon
127
RingCentral
RNG
$5.35B
$1.57M 0.12%
8,400
+1,000
+14% +$222K
CSGP icon
128
CoStar Group
CSGP
$12.5B
$1.55M 0.12%
19,600
-3,100
-14% -$260K
MRVI icon
129
Maravai LifeSciences
MRVI
$895M
$1.5M 0.11%
35,900
-5,000
-12% -$203K
DBX icon
130
Dropbox
DBX
$8.1B
$1.48M 0.11%
60,100
-12,900
-18% -$347K
COO icon
131
Cooper Companies
COO
$14.5B
$1.47M 0.11%
14,000
-2,000
-13% -$204K
XPO icon
132
XPO
XPO
$23.6B
$1.45M 0.11%
31,472
+8,247
+36% +$383K
PODD icon
133
Insulet
PODD
$9.79B
$1.44M 0.11%
5,400
-700
-11% -$203K
DHI icon
134
D.R. Horton
DHI
$42.1B
$1.4M 0.11%
12,900
-5,100
-28% -$491K
META icon
135
Meta Platforms (Facebook)
META
$1.51T
$1.35M 0.1%
4,015
-160
-4% -$53.1K
CHD icon
136
Church & Dwight Co
CHD
$24.5B
$1.34M 0.1%
13,125
-1,500
-10% -$136K
AHCO icon
137
AdaptHealth
AHCO
$795M
$1.33M 0.1%
+54,400
New +$1.28M
CPAY icon
138
Corpay
CPAY
$25.7B
$1.32M 0.1%
5,885
-600
-9% -$143K
FICO icon
139
Fair Isaac
FICO
$22.5B
$1.23M 0.09%
2,830
-1,650
-37% -$655K
OPEN icon
140
Opendoor
OPEN
$3.44B
$1.22M 0.09%
86,283
+54,250
+169% +$1M
TXG icon
141
10x Genomics
TXG
$6.39B
$1.07M 0.08%
7,200
+1,500
+26% +$230K
TMO icon
142
Thermo Fisher Scientific
TMO
$217B
$1.05M 0.08%
1,580
-65
-4% -$40.6K
QDEL icon
143
QuidelOrtho
QDEL
$841M
$1.05M 0.08%
7,800
-1,200
-13% -$167K
ABT icon
144
Abbott
ABT
$186B
$1.02M 0.08%
7,263
-300
-4% -$38.4K
HD icon
145
Home Depot
HD
$353B
$1.01M 0.08%
2,433
-84
-3% -$32K
COUP
146
DELISTED
Coupa Software Incorporated
COUP
$948K 0.07%
6,000
-3,700
-38% -$762K
JPM icon
147
JPMorgan Chase
JPM
$951B
$928K 0.07%
5,860
-59
-1% -$9.69K
MA icon
148
Mastercard
MA
$494B
$920K 0.07%
2,560
-120
-4% -$41.5K
ZTS icon
149
Zoetis
ZTS
$30.5B
$920K 0.07%
3,770
-145
-4% -$31.8K
TDG icon
150
TransDigm Group
TDG
$68.2B
$910K 0.07%
1,430
-300
-17% -$188K

Similar funds

Tributary Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Tributary Capital Management held 237 positions worth $1.32B, up 2.3% from $1.29B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Tributary Capital Management withdrew a net $106M in Q4 2021, closing 14 positions and reducing 173 holdings. Its most notable exit was DraftKings, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Industrials and Financials.

Against the trend, Tributary Capital Management opened a new position in Plug Power worth $1.95M.

  • Tributary Capital Management's largest Q4 2021 buy was Plug Power: 69,000 shares worth $1.95M.
  • Tributary Capital Management added most to LHC Group LLC in Q4 2021, an estimated $16M increase.
  • Tributary Capital Management's biggest Q4 2021 reduction was Medpace, cutting an estimated $16.9M.
  • Tributary Capital Management fully exited DraftKings in Q4 2021, selling an estimated $1.32M.
  • Tributary Capital Management's ten largest holdings make up 20% of its $1.32B portfolio in Q4 2021.
  • Tributary Capital Management opened 7 new positions and closed 14 in Q4 2021.
  • Tributary Capital Management's portfolio value rose 2.3% quarter-over-quarter to $1.32B.

Based on Tributary Capital Management's 13F filing for Q4 2021, filed 6 Jan 2022.